Back

Perceptions of a Gender-Neutral Approach to Human Papillomavirus (HPV) Vaccination in Cameroon: A Qualitative Study

Iliassu, S.; Mbanga, C.; Ngenge, M. B.; Ndoula, S.; Njoh, A. A.; Griffith, B. C.; Patel, S.; Singh, N.; Nebongo, D.; Bieme-Ndi, E. C.; Derrick, N. S.; Mngemane, S.; Ajayi, T.; Zultak, L. A.; Saidu, Y.

2025-05-01 public and global health
10.1101/2025.04.29.25326670 medRxiv
Show abstract

Cameroons Expanded Program on Immunization (EPI) introduced the HPV vaccine into the routine immunization schedule in Cameroon in October 2020. However, HPV vaccine coverage has remained low, reaching only 20% by December 2022. In response, a gender-neutral vaccination (GNV) approach was adopted and implemented from January 2023 to increase acceptance, reduce stigma, and improve vaccine coverage. This study aimed to assess the perceptions of key immunization stakeholders in Cameroon on the GNV approach to HPV vaccination. A cross-sectional study was conducted from June to September 2024 using an in-depth and semi-structured interviews to explore the perspectives of key stakeholders (policymakers, community leaders, and parents of girls aged 9-13 years) across three regions (South-West, North, and Centre) and the central level. Data was analyzed using traditional content analysis, via manual and NVivo coding to identify key themes. The research team ensured reliability through consensus discussions, and key quotes illustrating central findings were identified. A total of 51 participants were interviewed. Participants observed that the inclusion of boys in the HPV vaccination program contributed to a positive shift in community perceptions, dispelled misconceptions, and enhanced overall vaccine acceptance. However, challenges related to limited resources, lingering misinformation, and hesitancy from parents, religious leaders, and healthcare workers hindered the effective implementation of the GNV approach. Participants emphasized the need for improved partnerships, sensitization strategies, integration with existing health programs, and sustained funding to enhance community understanding and increase vaccination uptake. Overall, stakeholders viewed the GNV approach as effective for improving HPV vaccine acceptability and promoting equity, but emphasized the need for continuous investments and stronger community engagement to address challenges like limited resources, misinformation, and hesitancy.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS Global Public Health
293 papers in training set
Top 0.4%
18.2%
2
Vaccines
196 papers in training set
Top 0.3%
7.0%
3
Frontiers in Public Health
140 papers in training set
Top 0.6%
6.7%
4
Vaccine
189 papers in training set
Top 0.5%
6.7%
5
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.1%
6.2%
6
Vaccine: X
19 papers in training set
Top 0.1%
6.2%
50% of probability mass above
7
BMC Public Health
147 papers in training set
Top 1%
3.9%
8
PLOS ONE
4510 papers in training set
Top 41%
3.5%
9
BMJ Open
554 papers in training set
Top 6%
3.5%
10
BMJ Global Health
98 papers in training set
Top 1%
1.8%
11
Epidemiology and Infection
84 papers in training set
Top 1%
1.7%
12
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.7%
13
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 2%
1.7%
14
BMC Health Services Research
42 papers in training set
Top 1%
1.5%
15
International Journal of Environmental Research and Public Health
124 papers in training set
Top 5%
1.2%
16
Public Health
34 papers in training set
Top 1%
0.9%
17
F1000Research
79 papers in training set
Top 4%
0.9%
18
Emerging Infectious Diseases
103 papers in training set
Top 2%
0.9%
19
COVID
13 papers in training set
Top 0.2%
0.9%
20
Eurosurveillance
80 papers in training set
Top 1%
0.9%
21
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.6%
0.8%
22
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.7%
23
eClinicalMedicine
55 papers in training set
Top 2%
0.7%
24
Scientific Reports
3102 papers in training set
Top 76%
0.7%
25
JMIR Public Health and Surveillance
45 papers in training set
Top 4%
0.7%
26
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.3%
0.7%
27
PLOS Neglected Tropical Diseases
378 papers in training set
Top 6%
0.7%
28
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.9%
0.6%
29
BMC Medicine
163 papers in training set
Top 8%
0.6%
30
PLOS Medicine
98 papers in training set
Top 5%
0.6%